Showing results (1011-1020 of 1,240) with videos related to
Sort By:
Pageof 124
International Journal of Biological Macromolecules|May 20, 2026
Gold-containing compounds target an apicomplexan Thioredoxin reductase: Disclosing reactivity through structural and functional characterizationFederica Gabriele, Marta Palerma, Jala Bogard, et al.Frontiers in Molecular Neuroscience|November 21, 2024
Exposure to the antiretroviral drug dolutegravir impairs structure and neurogenesis in a forebrain organoid model of human embryonic cortical developmentEmma LaNoce, Daniel Y Zhang, Alan Garcia-Epelboim, et al.ACS Infectious Diseases|May 5, 2021
Probing the Surface of a Parasite Drug Target Thioredoxin Glutathione Reductase Using Small Molecule FragmentsFrancesca Fata, Ilaria Silvestri, Matteo Ardini, et al.European Journal of Neurology|May 18, 2020
Aggressive multiple sclerosis: a single-centre, real-world treatment experience with autologous haematopoietic stem cell transplantation and alemtuzumabG Boffa, C Lapucci, E Sbragia, et al.International Journal of Molecular Sciences|April 30, 2021
Nusinersen Modulates Proteomics Profiles of Cerebrospinal Fluid in Spinal Muscular Atrophy Type 1 PatientsLaura Bianchi, Maria Sframeli, Lorenza Vantaggiato, et al.Frontiers in Neurology|January 29, 2021
Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuSZbyšek Pavelek, Lukáš Sobíšek, Jana Šarláková, et al.Radiation Research|March 17, 2018
Estimates of Environmental Exposure to Radiofrequency Electromagnetic Fields and Risk of Lymphoma SubtypesG Satta, N Mascia, T Serra, et al.American Journal of Hematology|November 16, 2012
Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patientsBarbara Scappini, Giacomo Gianfaldoni, Francesco Caracciolo, et al.Journal of Neuroimmunology|October 2, 2007
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosisGiovanni Frisullo, Massimiliano Mirabella, Francesco Angelucci, et al.Current Cancer Drug Targets|June 29, 2010
Bone-targeted doxorubicin-loaded nanoparticles as a tool for the treatment of skeletal metastasesM Salerno, E Cenni, C Fotia, et al.Pageof 124